| James R Bellor Jr, MD | |
|
5450 Knoll North Dr, Suite 275, Columbia, MD 21045-2300 | |
| (410) 964-6139 | |
| (410) 740-8658 |
| Full Name | James R Bellor Jr |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 43 Years |
| Location | 5450 Knoll North Dr, Columbia, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710905377 | NPI | - | NPPES |
| P00228699 | Other | MD | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | D0039652 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bellor Leichtling Saway And Schneider Pc | 9436114931 | 16 |
News Archive
Quitting smoking sets off a series of changes in the brain that Penn Medicine researchers say may better identify smokers who will start smoking again—a prediction that goes above and beyond today's clinical or behavioral tools for assessing relapse risk.
A report in The Journal of Molecular Diagnostics, describes a new simple molecular test to detect chromosomal abnormalities - biomarkers known as telomere fusions-in pancreatic tumor specimens and pancreatic cyst fluids.
Medrium, Inc., one of the nation's top independent medical healthcare information technology companies, today announced it has signed a partnership agreement with RelayHealth to use their Results Distribution Systems (RDS) to leverage Relay's national relationship with LabCorp and to provide LabCorp results to physicians utilizing the Medrium EMR.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). A Prescription Drug User Fee Act (PDUFA) date will be established by the FDA regarding the review of the pixantrone NDA by September 4th 2009.
› Verified 2 days ago
| Entity Name | Bellor Leichtling Saway & Schneider Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558406017 PECOS PAC ID: 9436114931 Enrollment ID: O20041123001289 |
News Archive
Quitting smoking sets off a series of changes in the brain that Penn Medicine researchers say may better identify smokers who will start smoking again—a prediction that goes above and beyond today's clinical or behavioral tools for assessing relapse risk.
A report in The Journal of Molecular Diagnostics, describes a new simple molecular test to detect chromosomal abnormalities - biomarkers known as telomere fusions-in pancreatic tumor specimens and pancreatic cyst fluids.
Medrium, Inc., one of the nation's top independent medical healthcare information technology companies, today announced it has signed a partnership agreement with RelayHealth to use their Results Distribution Systems (RDS) to leverage Relay's national relationship with LabCorp and to provide LabCorp results to physicians utilizing the Medrium EMR.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). A Prescription Drug User Fee Act (PDUFA) date will be established by the FDA regarding the review of the pixantrone NDA by September 4th 2009.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James R Bellor Jr, MD 5450 Knoll North Dr, Suite 275, Columbia, MD 21045-2300 Ph: (410) 964-6139 | James R Bellor Jr, MD 5450 Knoll North Dr, Suite 275, Columbia, MD 21045-2300 Ph: (410) 964-6139 |
News Archive
Quitting smoking sets off a series of changes in the brain that Penn Medicine researchers say may better identify smokers who will start smoking again—a prediction that goes above and beyond today's clinical or behavioral tools for assessing relapse risk.
A report in The Journal of Molecular Diagnostics, describes a new simple molecular test to detect chromosomal abnormalities - biomarkers known as telomere fusions-in pancreatic tumor specimens and pancreatic cyst fluids.
Medrium, Inc., one of the nation's top independent medical healthcare information technology companies, today announced it has signed a partnership agreement with RelayHealth to use their Results Distribution Systems (RDS) to leverage Relay's national relationship with LabCorp and to provide LabCorp results to physicians utilizing the Medrium EMR.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). A Prescription Drug User Fee Act (PDUFA) date will be established by the FDA regarding the review of the pixantrone NDA by September 4th 2009.
› Verified 2 days ago
Dr. Jon Kent Minford, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 10710 Charter Dr, Suite G020, Columbia, MD 21044 Phone: 410-964-2212 Fax: 410-964-0380 | |
Dr. Jacob Cherian, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5450 Knoll North Dr, Columbia, MD 21045 Phone: 410-964-5311 Fax: 410-964-8578 | |
Dr. Tejaswi Rajasekhara Sastry, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr, Suite G020, Columbia, MD 21044 Phone: 410-964-2212 Fax: 410-964-0380 | |
Michael Howard Kelemen, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5450 Knoll North Dr, Suite 200b, Columbia, MD 21045 Phone: 410-964-5303 | |
Dr. Tin O Maung, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5999 Harpers Farm Rd, Suite W250, Columbia, MD 21044 Phone: 410-772-8822 Fax: 410-772-9274 | |
Dr. Jeffery Wayne Van Den Broek, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr, Suite 110, Columbia, MD 21044 Phone: 410-992-9797 Fax: 410-730-0942 | |
Angela M. Kopack, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 11055 Little Patuxent Pkwy, Suite 209, Columbia, MD 21044 Phone: 410-884-1311 Fax: 410-884-6033 |